Gemtuzumab and condition aggravated Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #4911216-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on June 27, 2003. Female patient, 75 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone pain, candidiasis, condition aggravated, fungal infection , hypertension, multi-organ failure, oedema peripheral, pleural effusion. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, VANCOMYCIN, SPORANOX. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #6119965-5
Gemtuzumab side effect was reported by a Physician from JAPAN on Mar 10, 2009. Female patient, 61 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, pneumonia , thrombocytopenia. Gemtuzumab dosage: 9 MG/M^2 ON DAY 1 AND 15. Patient died.

Gemtuzumab Side Effects Report #5061707-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on July 11, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase decreased, atelectasis, condition aggravated, enterococcal infection, fibrin d dimer increased, gamma-glutamyltransferase increased, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia. Gemtuzumab dosage: 3 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL, AMIKIN. Patient died.

Gemtuzumab Side Effects Report #5028040-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on May 30, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, pneumonia , prothrombin level increased, pseudomonal sepsis, white blood cell count decreased. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL, AMIKIN. Patient recovered.


Gemtuzumab Side Effects Report #5035412-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on June 09, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atelectasis, condition aggravated, fibrin d dimer increased, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, platelet count decreased, pneumonia , pseudomonal sepsis. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL TRANSDERMAL SYSTEM, AMIKIN. Patient recovered.

Gemtuzumab Side Effects Report #4589490-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Feb 10, 2005. Male patient, 37 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: capillary leak syndrome, condition aggravated, dyspnoea, fluid retention, hypoalbuminaemia, infection , lung infiltration, pleural effusion. Gemtuzumab dosage: 12.4 MG 1X PER 1 DAY. During the same period patient was treated with IDARUBICIN, CYTARABINE, ALLOPURINOL, ATENOLOL. Patient died.

Gemtuzumab Side Effects Report #4613932-6
Gemtuzumab side effect was reported by a Physician from on Mar 11, 2005. Male patient, 37 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: capillary leak syndrome, condition aggravated, hypoalbuminaemia, infection , lung infiltration. Gemtuzumab dosage: 12.4 MG 1X PER 1 DAY;. During the same period patient was treated with IDABRUBICIN, ALLOPURINOL, ATNOLOL. Patient died.

Gemtuzumab Side Effects Report #4628508-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, 37 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: capillary leak syndrome, condition aggravated, dyspnoea, fluid retention, hypoalbuminaemia, infection , lung infiltration, pleural effusion. Gemtuzumab dosage: 12.4 MG 1X PER 1 DAY. During the same period patient was treated with CYTARABINE, IDARUBICIN, ALLOPURINOL, ATENOLOL. Patient died.

Gemtuzumab Side Effects Report #5192195-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Dec 18, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, pneumonitis, septic shock, thrombocytopenia. Gemtuzumab dosage: 9.5 MG,. During the same period patient was treated with FUROSEMIDE, MEROPENEM, AMIKACIN, TEICOPLANIN. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4867127-1
Gemtuzumab side effect was reported by a Physician from SPAIN on Mar 10, 2002. Male patient, 20 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anuria, ascites, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, hypocalcaemia, liver disorder. Gemtuzumab dosage: 9 MG/M^2 1X PER 1 DOS INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5277131-X
Gemtuzumab side effect was reported by a Physician from BELGIUM on Mar 15, 2007. Male patient, weighting 186.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, condition aggravated, disseminated intravascular coagulation, hepatocellular damage, multi-organ failure. Gemtuzumab dosage: unknown. During the same period patient was treated with MERONEM, TARGOCID. Patient died on 03/23/2004.